Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Basic Science Article
  • Published:

Associations of maternal plasma and umbilical cord plasma metabolomics profiles with birth anthropometric measures

Abstract

Background

The metabolomics profiles of maternal plasma during pregnancy and cord plasma at birth might influence fetal growth and birth anthropometry. The objective was to examine how maternal plasma and umbilical cord plasma metabolites are associated with newborn anthropometric measures, a known predictor of future health outcomes.

Methods

Pregnant women between 24 and 28 weeks of gestation were recruited as part of a prospective cohort study. Blood samples from 413 women at enrollment and 787 infant cord blood samples were analyzed using the Biocrates AbsoluteIDQ® p180 kit. Multivariable linear regression models were used to examine associations of cord and maternal metabolites with infant anthropometry at birth.

Results

In cord blood samples from this rural cohort from New Hampshire of largely white residents, 13 metabolites showed negative associations, and 10 metabolites showed positive associations with birth weight Z-score. Acylcarnitine C5 showed negative association, and 4 lysophosphatidylcholines showed positive associations with birth length Z-score. Maternal blood metabolites did not significantly correlate with birth weight and length Z-scores.

Conclusions

Consistent findings were observed for several acylcarnitines that play a role in utilization of energy sources, and a lysophosphatidylcholine that is part of oxidative stress and inflammatory response pathways in cord plasma samples.

Impact

  • The metabolomics profiles of maternal plasma during pregnancy and cord plasma at birth may influence fetal growth and birth anthropometry.

  • This study examines the independent effects of maternal gestational and infant cord blood metabolomes across different classes of metabolites on birth anthropometry.

  • Acylcarnitine species were negatively associated and glycerophospholipids species were positively associated with weight and length Z-scores at birth in the cord plasma samples, but not in the maternal plasma samples.

  • This study identifies lipid metabolites in infants that possibly may affect early growth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Three plots present log10(p value) for the association between each metabolite or custom indicator/ratio and three newborn outcome measures (weight, length, and weight-for-length Z-scores) from the linear regression models.

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon request and completion of a satisfactory data transfer agreement.

References

  1. Bekhet, O. H. et al. Associations of Apgar score and size at birth with lipoprotein subclasses in juvenile obesity. Turk. J. Med. Sci. 47, 1804–1812 (2017).

  2. Ong, K. K. Size at birth, postnatal growth and risk of obesity. Horm. Res. Paediatr. 65, 65–69 (2006).

    CAS  Google Scholar 

  3. Novotny, R., Vijayadeva, V., Grove, J., Lim, U. & Le Marchand, L. Birth size and later central obesity among adolescent girls of Asian, white, and mixed ethnicities. Hawaii J. Med. Public Health 72, 50–55 (2013).

    PubMed  PubMed Central  Google Scholar 

  4. Kristiansen, A. L. et al. Tracking of body size from birth to 7 years of age and factors associated with maintenance of a high body size from birth to 7 years of age–the Norwegian Mother and Child Cohort study (MoBa). Public Health Nutr. 18, 1746–1755 (2015).

    PubMed  Google Scholar 

  5. Huxley, R. et al. Is birth weight a risk factor for ischemic heart disease in later life? Am. J. Clin. Nutr. 85, 1244–1250 (2007).

    CAS  PubMed  Google Scholar 

  6. Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet Lond. Engl. 2, 577–580 (1989).

    CAS  Google Scholar 

  7. Leon, D. A. et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 317, 241–245 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Nordman, H., Jääskeläinen, J. & Voutilainen, R. Birth size as a determinant of cardiometabolic risk factors in children. Horm. Res. Paediatr. 93, 144–153 (2020).

    CAS  PubMed  Google Scholar 

  9. Stacy, S. L. et al. Maternal obesity, birth size, and risk of childhood cancer development. Am. J. Epidemiol. 188, 1503–1511 (2019).

    PubMed  PubMed Central  Google Scholar 

  10. Vatten, L. J., Nilsen, T. I. L., Tretli, S., Trichopoulos, D. & Romundstad, P. R. Size at birth and risk of breast cancer: prospective population-based study. Int. J. Cancer 114, 461–464 (2005).

    CAS  PubMed  Google Scholar 

  11. Ahlgren, M. et al. Birth weight and risk of breast cancer in a cohort of 106,504 women. Int. J. Cancer 107, 997–1000 (2003).

    CAS  PubMed  Google Scholar 

  12. McCormack, V. A. et al. Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort. BMJ 326, 248 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Potischman, N. & Troisi, R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 10, 561–573 (1999).

    CAS  PubMed  Google Scholar 

  14. Vatten, L. J. et al. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br. J. Cancer 86, 89–91 (2002).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Sandhu, M. S., Luben, R., Day, N. E. & Khaw, K.-T. Self-reported birth weight and subsequent risk of colorectal cancer. Cancer Epidemiol. Prev. Biomark. 11, 935–938 (2002).

    Google Scholar 

  16. Hadden, D. R. & McLaughlin, C. Normal and abnormal maternal metabolism during pregnancy. Semin. Fetal Neonatal Med. 14, 66–71 (2009).

    PubMed  Google Scholar 

  17. McKeating, D. R., Fisher, J. J. & Perkins, A. V. Elemental metabolomics and pregnancy outcomes. Nutrients 11, 73 (2019).

  18. Koletzko, B. et al. The Power of Programming and the EarlyNutrition project: opportunities for health promotion by nutrition during the first thousand days of life and beyond. Ann. Nutr. Metab. 64, 187–196 (2014).

    CAS  PubMed  Google Scholar 

  19. Barker, D. J. & Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet Lond. Engl. 1, 1077–1081 (1986).

    CAS  Google Scholar 

  20. Dabelea, D. & Crume, T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60, 1849–1855 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Diaz, S. O. et al. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J. Proteome Res. 12, 2946–2957 (2013).

    CAS  PubMed  Google Scholar 

  22. Goodacre, R. & Kell, D. B. Evolutionary computation for the interpretation of metabolomic data. in Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis (eds Harrigan, G. G. & Goodacre, R.) 239–256 (Springer US, 2003). https://doi.org/10.1007/978-1-4615-0333-0_13.

  23. Horgan, R. P. et al. Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. J. Proteome Res. 10, 3660–3673 (2011).

    CAS  PubMed  Google Scholar 

  24. Liu, X. et al. Urinary metabolic variation analysis during pregnancy and application in Gestational Diabetes Mellitus and spontaneous abortion biomarker discovery. Sci. Rep. 9, 2605 (2019).

    PubMed  PubMed Central  Google Scholar 

  25. Kadakia, R. et al. Maternal metabolites during pregnancy are associated with newborn outcomes and hyperinsulinaemia across ancestries. Diabetologia 62, 473–484 (2019).

    CAS  PubMed  Google Scholar 

  26. Hellmuth, C. et al. Association of maternal prepregnancy BMI with metabolomic profile across gestation. Int. J. Obes. 41, 159–169 (2017).

    CAS  Google Scholar 

  27. Li, J. et al. Maternal PCaaC38:6 is associated with preterm birth – a risk factor for early and late adverse outcome of the offspring. Kidney Blood Press. Res. 41, 250–257 (2016).

    CAS  PubMed  Google Scholar 

  28. Ciborowski, M. et al. Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies. Prenat. Diagn. 34, 870–877 (2014).

    CAS  PubMed  Google Scholar 

  29. Colicino, E. et al. Non-linear and non-additive associations between the pregnancy metabolome and birthweight. Environ. Int. 156, 106750 (2021).

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Chia, A.-R. et al. Maternal plasma metabolic markers of neonatal adiposity and associated maternal characteristics: The GUSTO study. Sci. Rep. 10, 9422 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Hellmuth, C. et al. Maternal metabolomic profile and fetal programming of offspring adiposity: identification of potentially protective lipid metabolites. Mol. Nutr. Food Res. 63, e1700889 (2019).

    PubMed  Google Scholar 

  32. Kadakia, R. et al. Cord blood metabolomics: association with newborn anthropometrics and C-peptide across ancestries. J. Clin. Endocrinol. Metab. 104, 4459–4472 (2019).

    PubMed  PubMed Central  Google Scholar 

  33. Kadakia, R. et al. Cord blood metabolites associated with newborn adiposity and hyperinsulinemia. J. Pediatr. 203, 144–149.e1 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Vidarsdottir, H. et al. Does metabolomic profile differ with regard to birth weight? Pediatr. Res. 89, 1144–1151 https://doi.org/10.1038/s41390-020-1033-0 (2021).

  35. Perng, W., Rifas-Shiman, S. L., Sordillo, J., Hivert, M.-F. & Oken, E. Metabolomic profiles of overweight/obesity phenotypes during adolescence: a cross-sectional study in project viva. Obesity (Silver Spring) 28, 379–387 (2020).

    CAS  PubMed  Google Scholar 

  36. Ivorra, C. et al. Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J. Transl. Med. 10, 142 (2012).

    PubMed  PubMed Central  Google Scholar 

  37. Song, Y. et al. Plasma acylcarnitines during pregnancy and neonatal anthropometry: a longitudinal study in a multiracial cohort. Metabolites 11, 885 (2021).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Perng, W. et al. Associations of cord blood metabolites with perinatal characteristics, newborn anthropometry, and cord blood hormones in project viva. Metabolism 76, 11–22 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Young, B. E., Johnson, S. L. & Krebs, N. F. Biological determinants linking infant weight gain and child obesity: current knowledge and future directions. Adv. Nutr. 3, 675–686 (2012).

    PubMed  PubMed Central  Google Scholar 

  40. Castorino, K. & Jovanovič, L. Pregnancy and diabetes management: advances and controversies. Clin. Chem. 57, 221–230 (2011).

    CAS  PubMed  Google Scholar 

  41. Geraghty, A. A. et al. Maternal blood lipid profile during pregnancy and associations with child adiposity: findings from the ROLO study. PLoS One 11, e0161206 (2016).

    PubMed  PubMed Central  Google Scholar 

  42. Gilbert-Diamond, D. et al. Rice consumption contributes to arsenic exposure in US women. Proc. Natl Acad. Sci. USA 108, 20656–20660 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Balshaw, D. M., Collman, G. W., Gray, K. A. & Thompson, C. L. The Children’s Health Exposure Analysis Resource: enabling research into the environmental influences on children’s health outcomes. Curr. Opin. Pediatr. 29, 385–389 (2017).

    PubMed  PubMed Central  Google Scholar 

  44. Leek, J. et al. sva: Surrogate Variable Analysis. https://doi.org/10.18129/B9.bioc.sva (2020).

  45. WHO Multicentre Growth Reference Study Group. Reliability of anthropometric measurements in the WHO Multicentre Growth Reference Study. Acta Paediatr. Suppl. 450, 38–46 (2006).

    Google Scholar 

  46. Pang, Z., Chong, J., Li, S. & Xia, J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites 10, 186 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Wickham, H. & Ruiz, E. dbplyr: A ‘dplyr’ Back End for Databases (2020).

  48. Kassambara, A. ggpubr: ‘ggplot2’ Based Publication Ready Plots (2020).

  49. Slowikowski, K. ggrepel: Automatically Position Non-Overlapping Text Labels with ‘ggplot2’ (2020).

  50. Yoshida, K. & Bartel, A. tableone: Create ‘Table 1’ to Describe Baseline Characteristics with or without Propensity Score Weights (2020).

  51. Thévenot, E. A., Roux, A., Xu, Y., Ezan, E. & Junot, C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J. Proteome Res. 14, 3322–3335 (2015).

    PubMed  Google Scholar 

  52. Borum, P. R. Carnitine in neonatal nutrition. J. Child Neurol. 10, 2S25–2S31 (1995).

    Google Scholar 

  53. Mendelson, S. D. 10 – Nutritional supplements and metabolic syndrome. in Metabolic Syndrome and Psychiatric Illness (ed Mendelson, S. D.) 141–186 (Academic Press, 2008).https://doi.org/10.1016/B978-012374240-7.50012-7.

  54. Shenai, J. P., Borum, P. R., Mohan, P. & Donlevy, S. C. Carnitine status at birth of newborn infants of varying gestation. Pediatr. Res. 17, 579–582 (1983).

    CAS  PubMed  Google Scholar 

  55. Winter, S. C., Linn, L. S. & Helton, E. Plasma carnitine concentrations in pregnancy, cord blood, and neonates and children. Clin. Chim. Acta 243, 87–93 (1995).

    CAS  PubMed  Google Scholar 

  56. Novak, M., Monkus, E. F., Chung, D. & Buch, M. Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines. Pediatrics 67, 95–100 (1981).

    CAS  PubMed  Google Scholar 

  57. Yang, L., Zhang, Y., Yang, J. & Huang, X. Effects of birth weight on profiles of dried blood amino-acids and acylcarnitines: Ann. Clin. Biochem. 55, 92–99 https://doi.org/10.1177/0004563216688038 (2018).

  58. Liu, Q. et al. Analysis of amino acids and acyl carnitine profiles in low birth weight, preterm, and small for gestational age neonates. J. Matern. Fetal Neonatal Med. 30, 2697–2704 (2017).

    CAS  PubMed  Google Scholar 

  59. Gucciardi, A. et al. Analysis and interpretation of acylcarnitine profiles in dried blood spot and plasma of preterm and full-term newborns. Pediatr. Res. 77, 36–47 (2015).

    PubMed  Google Scholar 

  60. Honzík, T. et al. Carnitine concentrations in term and preterm newborns at birth and during the first days of life. Prague Med. Rep. 106, 297–306 (2005).

    PubMed  Google Scholar 

  61. Robinson, O. et al. Cord blood metabolic signatures of birth weight: a population-based study. J. Proteome Res. 17, 1235–1247 (2018).

    CAS  PubMed  Google Scholar 

  62. D’Arrigo, P. & Servi, S. Synthesis of lysophospholipids. Molecules 15, 1354–1377 (2010).

    PubMed  PubMed Central  Google Scholar 

  63. Law, S.-H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 20, 1149 (2019).

  64. Prieto-Sánchez, M. T. et al. Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes. Clin. Nutr. 36, 513–521 (2017).

    PubMed  Google Scholar 

  65. Hellmuth, C. et al. Cord blood metabolome is highly associated with birth weight, but less predictive for later weight development. Obes. Facts 10, 85–100 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Lu, Y.-P. et al. Cord blood lysophosphatidylcholine 16: 1 is positively associated with birth weight. Cell. Physiol. Biochem. 45, 614–624 (2018).

    CAS  PubMed  Google Scholar 

  67. Freigang, R. et al. Misclassification of self-reported body mass index categories. Dtsch. Ärztebl. Int. 117, 253–260 (2020).

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the children and families who made this study possible and to the staff of the New Hampshire Birth Cohort Study.

Funding

This research was funded by the National Institutes of Health of Environmental Health Sciences, grant numbers P01ES022832 and P20ES018175, the National Institute of Diabetes and Digestive and Kidney Diseases, grant number U24DK097193, the Office of the Director, grant number UH3OD023275, and the National Institute of General Medical Sciences, grant number P20GM104416. The study sponsors had no role in study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the paper for publication.

Author information

Authors and Affiliations

Authors

Contributions

M.R.K. and S.S. designed and supervised the data collection. A.G.H., D.G.-D., S.S., S.M. and M.R.K. conceptualized the study. D.Y. analyzed the data and wrote the first draft of the manuscript. All co-authors (D.G.-D., B.D., M.C., D.S., D.K., S.M., S.S., M.R.K., and A.G.H.) read, edited several draft versions, and approved the final manuscript.

Corresponding author

Correspondence to Dabin Yeum.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

All study procedures were approved by the Center for the Protection of Human Subjects at Dartmouth College (protocol code STUDY00020844). All participants provided written informed consent after they were explained the aims of the study, the procedure of the data collection, and voluntary nature of participation that they were free to withdraw from the study at any time.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yeum, D., Gilbert-Diamond, D., Doherty, B. et al. Associations of maternal plasma and umbilical cord plasma metabolomics profiles with birth anthropometric measures. Pediatr Res 94, 135–142 (2023). https://doi.org/10.1038/s41390-022-02449-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41390-022-02449-2

This article is cited by

Search

Quick links